Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF627 Activators

Chemical activators of ZNF627 can influence the protein's functionality through various biochemical pathways. Zinc Chloride is a direct supplier of zinc ions, which are essential for maintaining the structural stability of the zinc finger domains within ZNF627. The availability of zinc ions is critical for the proper conformation and the DNA-binding activity of ZNF627, which is a prerequisite for its role in transcriptional activation. Another activator, Forskolin, raises intracellular cAMP levels, thereby activating protein kinase A (PKA). The activation of PKA can lead to the phosphorylation of ZNF627 on serine and threonine residues, resulting in its activation. Similarly, Phorbol 12-myristate 13-acetate (PMA) stimulates protein kinase C (PKC), which can also target ZNF627 for phosphorylation, enhancing its activity. The action of Ionomycin, which increases intracellular calcium levels, can lead to the activation of calmodulin-dependent protein kinases that are capable of phosphorylating ZNF627.

Furthermore, Thapsigargin can elevate cytosolic calcium concentrations by inhibiting the SERCA pump, which indirectly leads to the activation of calcium-responsive kinases that can phosphorylate ZNF627. Anisomycin acts as an activator by stimulating stress-activated protein kinases, which may phosphorylate ZNF627, thereby activating it. Inhibitors of protein phosphatases such as Calyculin A and Okadaic Acid result in sustained phosphorylation states of target proteins like ZNF627 by preventing their dephosphorylation, which maintains ZNF627 in an active form. LY294002, a PI3K inhibitor, can lead to the activation of alternative pathways that may include kinases capable of activating ZNF627 through phosphorylation. Bisindolylmaleimide I and H-89, both inhibitors of PKC and PKA respectively, can similarly induce the activation of alternative pathways which may result in the phosphorylation and activation of ZNF627. Lastly, Dibutyryl-cAMP, a cAMP analog, directly activates PKA, which in turn can phosphorylate ZNF627 and promote its activation. Each of these chemicals can activate ZNF627 by influencing the phosphorylation state, either directly or through the modulation of upstream kinases and phosphatases.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Zinc Chloride can provide zinc ions necessary for the structural integrity of the zinc finger domains in ZNF627. Presence of zinc ions is crucial for the proper folding and function of zinc finger proteins, which in turn ensures their DNA binding capability and transcriptional activation role.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC) which may phosphorylate serine residues on ZNF627, potentially leading to its activation.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin raises intracellular calcium levels, which can activate calmodulin-dependent protein kinases. These kinases can phosphorylate and thereby activate ZNF627.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits SERCA, leading to increased intracellular calcium levels, which could activate calcium-dependent kinases that phosphorylate and activate ZNF627.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates stress-activated protein kinases (SAPKs), which may target and phosphorylate ZNF627, leading to its activation.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A inhibits protein phosphatases 1 and 2A, leading to a sustained phosphorylation state of proteins. This could maintain ZNF627 in an active phosphorylation state.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid, similar to Calyculin A, inhibits protein phosphatases which would otherwise dephosphorylate proteins like ZNF627, thereby maintaining ZNF627 in a functionally active state.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which can lead to activation of compensatory pathways that may include kinases able to phosphorylate and activate ZNF627.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I is a PKC inhibitor that may lead to the activation of compensatory pathways or kinases that could phosphorylate and activate ZNF627.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP, a cAMP analog, directly activates PKA, which can phosphorylate and thereby activate ZNF627.